The Benefic Effects of Cannabis on Patients with Multiple Sclerosis


According to recently performed experiments, cannabis may be regarded as an effective treatment for patients diagnosed with multiple sclerosis. While in the beginning the symptomatic improvements experienced by patients with multiple sclerosis who have been administered cannabinoid products have been thought to be determined solely by mental elements, eventually studies have revealed that cannabis truly reduces muscular spasms as well as stiffness distinctive to multiple sclerosis patients. The benefic effects of cannabis on people with multiple sclerosis were confirmed by short-term and long term controlled health studies.
In 2003, a team of researchers from the Peninsula Medical School in Exeter, UK are making public the results of a series of short-term and long-term studies on the consequences of cannabinoids among people with multiple sclerosis. The previously conducted research involved the active participation of approximately 600 patients with advanced-stage multiple sclerosis. The participants were split in 2 distinctive groups: the very first team got cannabinoid compounds in equal doses, while the second group received placebo pills over a period of 15 weeks. By the end of the test, the bulk of people who happened to be administered cannabinoids experienced a great deal of symptomatic improvements, having less muscular pain condor cbd gummies and tinnitus being confronted with milder muscular spasticity (less pronounced muscular spasm). Unlike the group which received cannabinoid compounds over the whole time of the study, the management group (patients that received placebo medications) skilled no advancements in their overall condition.
To be able to establish the relevancy of the findings and to discard any doubts related to the performance of cannabis in ameliorating the indications of multiple sclerosis, the research was later repeated. The ulterior analysis was carried out over a period of twelve weeks, as well as involved the participation of the exact same subject areas. Nevertheless, this time the participants had been divided into 3 distinct groups instead of two as in the case of the previous test. The earliest team received pills of D9 tetrahydrocannabinol (THC) - the active part in cannabis, the second group got natural cannabis extracts, while the third group received placebo medications.
At the conclusion of the experiment, patients were meticulously evaluated as well as examined by a team of neurologists and physiotherapists. The most effective results happened to be obtained among the patients belonging to the pioneer study group, the majority of subjects that have received equal doses of THC experiencing considerable progress in the symptoms of theirs. The patients in the second study group experienced slight improvements in their symptoms, while the patients in the third group experienced no changes in their condition.
Regardless of the fact these studies clearly claim that cannabis is a good solution for multiple sclerosis, health-related experts are not still convinced that cannabinoids can be used successfully in the curing of many sclerosis. But, after performing additional studies on the situation plus more elaborate research, doctors may consider to introduce cannabinoid compounds in the healing of several sclerosis in the future.